Instytut Zdrowia Boczarska
Oświęcim 32-600
0 studies enrolling now · 1 studies all time
What they study most
Multiple Sclerosis, Relapsing-Remitting
Studies at this site
Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
— Running, not enrolling